The generation of g-Glutamyl-Peptide via GCLC is regulated by the KEAP1-NRF2 pathway [108], indicating a potential treatment for NSCLC by targeting the KEAP1-NRF2 pathway. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.